Abstract
It is possible that heparin-like sulfated polysaccharides from red algae, or fractions thereof, might be found to be low-cost, broad-spectrum antiviral agents. The prevailing view among virologists has been that sulfated polysaccharides inhibit viral action by acting only at the surfaces of cells. This perception now is changing with the finding that both the herpes virus (containing DNA) and human immunodeficiency virus (containing RNA) are inhibited by sulfated polysaccharides that act within the cell as well as external to it. Aqueous extracts of many red algae are active against retroviruses. Carrageenan, a common cell wall polysaccharide from red algae, is co-internalized into infected cells with the Herpes simplex virus (HSV), inhibiting the virus. Carrageenan also interferes with fusion (syncytium formation) between cells infected with the human immunodeficiency virus (HIV) and inhibits the specific retroviral enzyme reverse transcriptase.
Similar content being viewed by others
References
Abraham, R., K. F. Benitz, R. Mankes & I. Rosenblum, 1985. Chronic and subchronic effects of various forms of carrageenan in rats. Ecotoxicol. Envir. Saf. 10: 173–183.
Abrams, D., M. Gottlieb, M. Grieco, M. Speer & S. Bernstein, 1988. AIDS/HIV Experimental Treatment Directory. American Foundation for Aids Research, N.Y., 118 pp.
Alarcon, B., J. C. Lacal, J. M. Fernandez-Sousa & L. Carrasco, 1984. Screening for new compounds with antiherpes activity. Antiviral Res. 4: 231–244.
Bauer, D. J., 1985. A history of the discovery and clinical application of antiviral drugs. Br. med. Bull. 41: 309–314.
Baba, M., R. Pauwels, J. Balzarini, J. Arnout, J. Desmyter & E. De-Clercq, 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA. 85: 6132–6136.
Blunden, G., C. J. Barwell, K. J. Fidgen & K. Jewers, 1981. A survey of some British marine algae for anti-influenza virus activity. Bot. mar. 24: 267–272.
Calvin, N. I. & R. J. Ellis, 1979. Water Soluble Extracts of Certain Marine Red Algae and Processes for Use Thereof. U.S. Patents 4,162,308, and 4,162,309.
Chong, A. S.-F. & C. R. Parish, 1985. Non-immune lymphocyte-macrophage interaction II. Evidence that the interaction involves sulfated polysaccharide recognition. Cell. Immunol. 92: 277–289.
De Clercq, E., J. Descamps, G. Verhelst, R. Walker, A. Jones, P. Torrence & D. Shugar, 1980. Comparative efficacy of antiherpes drugs against different strains of Herpes simplex virus. J. Inf. Dis. 141: 563–574.
Dhargalkar, V. K., T. G. Jagtap & A. G. Untawale, 1980. Biochemical constituents of seaweeds along the Maharashtra coast. Ind. J. Mar. Sci. 9: 297–299.
Delahunty, T., L. Recher & D. Hollander, 1987. Intestinal permeability changes in rodents: A possible mechanism for degraded carrageenan-induced colitis. Fd Chem. Toxic. 25: 113–118.
Dziarski, R., 1989. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin. J. Immunol. 143: 356–365.
Ehresmann, D. W., E. F. Deig, M. T. Hatch, L. H. Di Salvo & N. A. Vedros. 1977. Antiviral substances from California marine algae. J. Phycol. 13: 37–40.
Ehresmann, D. W.,E. F. Deig & M. T. Hatch, 1979. Antiviral properties of algal polysaccharides and related compounds. In H. A. Hoppe, T. Levring & Y. Tanaka (eds), Marine Algae in Pharmaceutical Science, W. de Gruyter, N.Y.: 293–302.
Fetter, R. & M. Neushul, 1981. Studies on developing and released spermatia in the red alga, Tiffaniella snyderae (Rhodophyta). J. Phycol. 17: 141–159.
Gonzalez, M. E., B. Alarcon & L. Carrasco, 1987. Polysaccharides as antiviral agents: Antiviral activity of carrageenan. Antimicrob. Agents Chemother. 31: 1388–1393.
Hatch, M. T., D. W. Ehresmann & E. F. Deig, 1979. Chemical characterization and therapeutic evaluation of antiHerpesvirus polysaccharides from species of Dumontiaceae. In H. A. Hoppe, T. Levring & Y. Tanaka (eds), Marine Algae in Pharmaceutical Science. W. de Gruyter, N.Y.: 343–363.
Hodgson, L. M., 1984. Antimicrobial and antineoplastic activity in some South Florida seaweeds. Bot. mar. 28: 387–390.
Hornsey, I. S. & D. Hide, 1974. The production of antimicrobial compounds by British marine algae. 1. Antibiotic producing marine algae. Br. phycol. J. 9: 353–361.
Mitsuya, H., D. J. Looney, S. Kuno, R. Ueno, F. Wong-Staal & S. Broder, 1988. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4 + cells. Science 240: 646–649.
Muller, W. E. G., 1979. Mechanisms of action and pharmacology: Chemical agents. In G. J. Galasso, T. C. Merigan & R. A. Buchanan (eds), Antiviral Agents and Viral Diseases of Man. Raven Press, N.Y.: 77–150.
Nagumo, T. & H. Hoshino, 1988. Heparin inhibits infectivity of human immunodeficiency virus in vitro. Jpn. J. Cancer Res. (Gann) 79: 9.
Nakashima, H, Y. Kido, N. Kobayashi, Y. Motoki, M. Neushul & N. Yamamoto, 1987a. Antiretroviral activity in a marine red alga: reverse transcriptase inhibition by an aqueous extract of Schizymenia pacifica. J. Cancer Res. Clin. Oncol. 113: 413–416.
Nakashima, H., Y. Kido, N. Kobayashi, Y. Motoki, M. Neushul & N. Yamamoto, 1987b. Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae. Antimicrob. Agents Chemother. 31: 1524–1528.
Nara, P. L. & P. J. Fischinger, 1988. Quantitative infectivity assay for HIV-1 and 2. Nature 332: 469–470.
Neushul, M., 1988. Method for the treatment of AIDS virus and other retroviruses. U.S. Patent no. 4,783,446.
Nonomura, A. L., 1985. Composition of matter from Cryptosiphonia woodii useful for the treatment of Herpes simplex virus. United States Patent no. 4,522,814.
Onderdonk, A. B., 1985. Experimental models for ulcerative colitis. Dig. Dis. Sci. (suppl.) 30: 40S–44S.
Pesando, D. & B. Caram, 1984. Screening of marine algae from the French Mediterranean coast for antibacterial and antifungal activity. Bot. mar. 28: 381–386.
Rada, B., D. Blaskovic, F. Sorm & J. Skoda, 1960. The inhibitory effect of 6-azauracil riboside on the multiplication of vaccinia virus. Experientia 16: 487.
Ragan, M. A., 1984. Bioactivities in marine genera of Atlantic Canada: The unexplored potential. Proc. N. S. Inst. Sci. 34: 83–132.
Richards, J. T., E. R. Kern, L. Glasgow, J. Overall, E. Deig & M. Hatch, 1978. Antiviral activity of extracts from marine algae. Antimicrob. Agents Chemother. 14: 24–30.
Schaffrath, D., H. W. Stuhlsatz & H. Greiling, 1976. Interactions of glycosaminoglycans with DNA and RNA synthesizing enzymes in vitro. Z. Physiol. Chem. 357: 499–508.
Sellin, J. H. & H. Oyarzabal, 1988. Carrageenan-induced colitis alters ion transport in rabbit colon in vitro. In R. P. MacDermott (ed.), Inflammatory Bowel Disease: current status and future approach. Elsevier, N.Y.: 391–396.
Silverstein,A. M.,1989. AHistory of Immunology. Academic Press, N.Y., 422 pp.
Solomon, J. J., K. A. Glatt & W. Okazaki, 1966. Inhibitory effect of heparin on Rous Sarcoma virus. J. Bact. 92: 1855–1856.
Thomson, A. W. & E. F. Fowler, 1981. Carrageenan: a review of its effects on the immune system. Agents Actions 11: 265–273.
Ueno, R. & S. Kuno, 1987. Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet 1: 1379.
Untawale, A. G., N. B. Bhosle & V. K. Dhargalkar, 1977. Properties of phycocolloid extracts from seaweeds of Goa. Ind. J. Mar. Sci. 6: 181–183.
Whyte, J. N. C., R. E. Foreman & R. E. DeWreede, 1984. Phycocolloid screening of British Columbian red algae. Proc. int. Seaweed Symp. 11: 537–541.
Wood, M. J. & A. M. Geddes, 1987. Antiviral Therapy. Lancet 1: 1189–1192.
Author information
Authors and Affiliations
Additional information
A shorter version of this paper was presented on February 24th, 1989, at the International Conference on Bioactive Compounds from Marine Organisms, Fort Aguada, Goa, India.
I dedicate this paper to the memory of my late friend and colleague, Bond Brinkhuis, who requested that I present it at the 13th International Seaweed Symposium, August, 1989.